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Summary: Data on 15 laboratory analytes obtained in 145 prospectively investigated cholestatic patients with
viral hepatitis, chronic intrahepatic cholestasis and extrahepatic biliary obstruction were submitted to a
computer-based graphical evaluation using probabilistic test analysis. This revealed a marginal utility for
alkaline phosphatase, y^glutamyltransferase and the direct/total bilirubin ratio at specific cut-off points for
the exclusion of extrahepatic cholestasis (PVneg 90% —100%). Aspartate aminotransferase and alanine
aminotransferase values with cut-off points at 200 U/l and 300 U/l, respectively, were powerful discriminators
between acute viral hepatitis and the other disease categories, while lactate dehydrogenase, erythrocyte
sedimentation rate and the ratios Y^glutamyltransferase/alanine aminotransferase as well as total bilirubin/γ-
glutamyltransferase were useful at specific cut-off points indicating the absence of this diagnosis (PVneg
92% —100%). An aspart te aminotransferase/alanine aminotransferase ratio above 1.5 and serum γ-globulin
concentrations above 20 g/1 strongly suggested cholestasis due to chronic parenchymal liver disease (PVpos
92% and 90%, respectively).
This graphical approach to laboratory data analysis enhances the understanding of the interrelations between
cut-off points and sensitivity, specificity and predictive values and also of the influence of disease prevalence
on disease prediction. It also adds to present knowledge by demonstrating the clinical relevance of several
readily available, albeit rarely utilized diagnostic analytes.
Introduction of a set of biochemical variables. It aims at a prelim-
TM. j-rr χ- ι j· - r· ι. ι · · τ. Λ inary assignment of each patient of either one of theThe differential diagnosis of cholestasis is based on a . β . . r . M. , . ., -, , ,. . , ° . . two major diagnostic categories intrahepatio andthorough clinical examination and on morphological M , · . „ , . A . °,. , .. A , .Al. ,, r<ul_ , Λ , .,. « ι extrahepatic cholestasis, which are listed with somestudies of the »hepatobiliary system by one or several r - %. . ,,'
A , . ι * j u u - ^ i · ι further refinement in table 1.imaging techniques, supplemented by an histological
evaluation of liver tissues in selected patients. The Biochemical profiles are often useful for the reliable
initial clinical examination includes an analysis of the classification of patients into those suffering from
patient's history, of his or her physical symptoms, and acute parenchymal liver disease, with viral hepatitis
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(VIR) as a hallmark (group Bl in tab. 1), or those
suffering from chronic parenchymal liver disease
(CHR) with cirrhosis, chronic hepatitis or chronic
alcoholic liver disease as the main variants (group B2
in tab. 1). However, in cases with predominant bile
stasis, it is widely accepted that clinical chemical pa-
rameters do not reliably differentiate between intra-
hepatic bile secretory failures or an extrahepatic bil-
iary obstruction (EXT) (1). In this paper we have
examined the usefulness of computer-assisted graph-
ical analyses of laboratory data for the differential
diagnosis of various hepatobiliary disease categories
in prospectively evaluated cholestatic patients.
Patients and Methods
This study included 145 consecutive patients with cholestasis,
which could be assigned to either one of four diagnostic cate-
gories as outlined in table 1, based on the results of imaging
studies (hepatobiliary ultrasound, cholescintigraphyj or endo-
scopic retrograde cholangiography) ana/or histologic or intra-
operative findings, and also the clinical outcome. No attempt
was made to differentiate between malignant or benign causes
of extrahepatic cholestasis (EXT, tab. 1) by means of laboratory
data. Criteria for cholestasis to be met before inclusion in this
study were: bilirubin ^ 2.0 mg/di (34 μιηοΐ/ΐ); γ-glutamyltrans-
ferase > 100 U/l; alkaline phosphatase ^ 300 U/l (at least two
of these three conditions) or serum bilirubin > 4 mg/dl (68
μηιοΐ/ΐ). Morphological diagnostic proof either by direct chol-
angiography and/or histological and/or intraoperative or post-
mortem findings was obtained in 104/145 patients (72%).










benign, mostly lithogenic cause
obstruction by malignant cause
Intrahepatic cholestasis (INT)
acute viral hepatitis (VIR)





























Alkaline phosphatase 180 U/l
γ-Glutamyltransferase 28 U/l
Leucine aminopeptidase 32 U/l
Aspartate aminotransferase 20 U/l
Alanine aminotransferase 20 U/l
Lactate dehydrogenase 250 U/l
Cholinesterase 2000* U/l
Total serum bilirubin 1.0 mg/dl
Direct bilirubin
Erythrocyte sedimentation rate
first hour 10 mm
second hour 20 mm
Immunoglobulin G 18 g/l
Immunoglobulin A 4.5 g/1
Immunoglobulin M 2.5 g/l
Total γ-globulin 10 g/i
Test criteria



































Specificity: fraction of test-negative reference persons among all reference persons
PVpos: (predictive value positive); "diseased" among
PVneg: (predictive value negative); reference persons
Youden index: (sensitivity + specificity) — 100%
Values in the diseased/reference groups above the thresholds
all test-positive persons
among all test-negative persons
indicated in this table were reduced and
categories for this individual analyte. E.g., a value of 1600 U/l for alkaline phosphatase was included





to" upper normal limits
except for cholinesterase*, where it denotes lower normal limit). "Hitachi" refers to Hitachi Automatic Analyzer 705
the Behring Laser Nephelometer-Analyzer.
, "Laser" to
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A set of 15 laboratory analytes summarized in table 2 was
routinely evaluated at the presentation of patients. In addition,
several analytes were also used to compute ratios as indicated
in table 3. These data were further evaluated by a graphical
computer program (2). Briefly, this program produces double
histograms presenting the distribution of laboratory data in
both "diseased" and reference groups in the study. Each con-
tinual diagnostic variable was arbitrarily divided into 10 test
classes. The probabilistic variables, sensitivity (sens), specificity
(spec), predictive value positive (PVpos), predictive value neg-
ative (PVneg) and Youden index (tab. 2; see also 1. c. (2, 3)) are
superimposed on the histograms as functions of the cut-off
laboratory values at any selected position. These discriminators
basically serve to reduce the data to a two-class (binary) test
equivalent to a 2 χ 2 table, which is the prerequisite for com-
puting the probabilistic test data for that specific cut-off point.
In order to compare the predictive values of the tests, the data
of each test were also recalculated to meet a "standard" prev-
alence of 50% "diseased". This computer program has been
described in detail elsewhere (2). The various hypotheses graph-
ically analysed in the present study are summarized in table 3.
The original data are available on request from the first author.
Results
Extrahepatic versus intrahepatic cholestasis
A synopsis of all relevant diagnostic results from the
graphical analyses is given in tables 4-6. When max-
imal efficiency as indicated by the highest Youden
index was used as the cut-off point, none of the
analytes investigated was of value for the basic dif-
ferentiation between extrahepatic obstruction or in-
trahepatic cholestasis due to acute or chronic paren-
chymal liver disease. This likewise applied to the ratio
of direct and total serum bilirubin (direct bilirubin/
total bilirubin). The double histograms for alkaline
phosphatase and direct bilirubin/total bilirubin are
reproduced in figure 1 and figure 4. However, when
selected discriminator positions for alkaline phospha-


































































































The diagnostic power of the indicated analyte in differentiating a "diseased" group (as defined in the second column) from the
corresponding complementary group not featuring this disease is analysed by probabilistic test parameters as a function of
variable discriminatory cut-off points. The diseased target group may be characterized by either high or low values of the
respective analyte. Abbreviations of patient groups: EXT, extrahepatic cholestasis; VIR, acute viral hepatitis; CHR, chronic
intrahepatic cholestasis.




































































































"diseased" patients are represented by low values
J. Clin. Chem. Clin. Biocherou / Vol. 26,1988 / No. 8
512 B rsch et al.: Graphical analysis of laboratory data in cholestasis
























































































































































* "diseased" patients are represented by low values
















































































































* "diseased" patients are represented by low values
tase, γ-glutamyltransferase (fig. 2) and direct biliru-
bin/total bilirubin at 300 U/l, 100 U/l, and 0.4, re-
spectively, were used as cut-off points, these analytes
did reveal some marginal utility for the exclusion of
extrahepatic obstruction (PVneg 92%, 90% and
100%, respectively, when the prevalence of obstruc-
tion is 44%; or 89%, 88% and 100%, respectively,
for a calculated "standard" prevalence of 50%). The
analytes leucine aminopeptidase (fig. 3) and IgM (fig.
5) were of no value in this regard.
Viral hepat i t is versus other hepatobi l iary dis-
eases
A number of analytes were useful for differentiating
between acute viral hepatitis and the remaining three
diagnostic categories. At a cut-off point of 200 U/l
or 300 U/l, respectively, aspartate aminotransferase
and alanine aminotransferase (figs. 6 and 7) were
powerful discriminators with very high Youden indices
well above 80% resulting from sensitivities and spec-
ificities of 90% or higher. Values below these cut-off
levels reliably excluded acute viral hepatitis (PVneg
98% and 99% respectively, when the prevalence of
VIR is 16%, or 91 % and 96% for a calculated "stand-
ard" prevalence; tab. 5 and fig. 6-7). We also found
that lactate dehydrogenase (fig. 8), the ratio of total
bilirubin/Y-glutamyltransferase (fig. 11) and γ-gluta-
myltransferase/alanine aminotransferase (fig. 10) and
the erythrocyte sedimentation rate (fig. 9) are useful
at certain cut-off points not necessarily coinciding
with maximal efficiency. Values below (lactate dehy-
drogenase, total bilirubin/y-glutamyltransferase) or
above (γ-glutamyltransferase/alanine aminotrans-
ferase, erythrocyte sedimentation rate 1 h, erythrocyte
sedimentation rate 2 h) these discriminators, as indi-
cated in table 5, made the diagnosis of viral hepatitis
very unlikely (PVneg 92% -100%; prevalence of VIR
16%; see also figs. 6-11),
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PVneg 74 %> PVpos 64 V«
Fig. 1. Double histogram of alkaline phosphatase values in
patients with extrahepatic cholestasis (= EXT) ("dis-
eased" (= Dis); η = 63; top of graph) versus intrahe-
patic cholestasis (viral hepatitis = VIR, chronic paren-
chymal liver disease = CHR) ("reference" (= Ref);
η = 81; bottom of graph). The number of diseased and
reference patients for each category of alkaline phos-
phatase values in U/l is indicated, with alkaline phos-
phatase missing in 1 patient of the "diseased" group.
The graph simultaneously displays sensitivity (sens)
( ), specificity (spec) ( ), Youden index
( ), the predictive value positive (PVpos)
( — · — ·—) and the predictive value negative (PVneg)
( ) as a function of any randomly selected alkaline
phosphatase value serving as discriminator (DISCR).
For instance, at a cut-off point of 400 U/l representing
the highest Youden index, alkaline phosphatase has a
sensitivity of 68%, a specificity of 70%, a Youden index
of 38%, a PVpos of 64% and a PVneg of 74% (or 69%
and 69%, respectively, at a computed "standard" dis-
ease prevalence (PREV) of 50%) for extrahepatic cho-
lestasis, and thus appears to be useless. In contrast, a
cut-off point of 300 U/l, not coinciding with maximal
efficiency, is clinically more useful since values below
this level indicate absence of disease with a PVneg of
92% (or 89% at a computed "standard" disease prev-
alence). To calculate "%" the values of the right ordinate
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PVneg 90°/0 PVpos 50%
Fig. 2. γ-Glutamyltransferase has a marginal usefulness for ex-





DISCR 60 U/l aminopeptidase PREV 43%
1.0
PV neg 73 %> PVpos 59β/ο
Fig. 3. Leucine aminopeptidase is useless in the differentiation
between extrahepatic and intrahepatic cholestasis.
Chronic parerichymal liver disease versus oth-
ers
For the differentiation between chronic parenchymal
liver disease and the three other complementary dia-
gnostic categories, the ratio of aspartate aminotrans-
ferase/alanine aminotransferase (fig. 12) and the
serum γ-globulin level (fig. 13) were the most useful
serological analytes (tab. 6). The Youden indices
ranged from 45% to 69%. Above a cut-off point of
1.5 and 20 g/1, respectively, the ratio aspartate ami-
notransferase/alanine aminotransferase and the serum
γ-globulin concentrations strongly suggested chronic
intrahepatic cholestasis with a PVpos of 92% and
90% for a prevalence of CHR of 40%, or 95% and
94% for a "standard" disease prevalence. There was
also a high PVpos for very high values of IgG above
36 g/1 and of IgA above 9 g/1 (figs. 14-15). However,
this was merely of minor diagnostic relevance, since
the latter criteria applied to no more than 5 (8.6%)
and 11 (19.6%) patients of the CHR category.
J. Clin. Chem. Clin. Biochem. / Vol. 26,1988 / No. 8
514 B rsch et al.: Graphical analysis of laboratory data in cholestasis
Direct bilirubin



























































































PVneg 100% PVpos 42%
Fig. 4. Double histogram of the ratio of direct and total bili-
rubin in patients with extrahepatic cholestasis ("dis-
eased"; η = 40; top of graph) versus intrahepatic cho-
lestasis ("reference"; η = 63; bottom of graph). This
ratio was computed in patients with elevated total serum
bilirubin concentrations only. Computation of this ratio
is of no diagnostic use, except for values below a cut-
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PVneg 98% PVpos 78%
Fig. 6. At a cut-off point of 200 U/l, aspartate aminotransferase
is a powerful disciminator between viral hepatitis and
the other forms of hepatobiliary diseases (for further
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79 Ref (VIR + CHR)
PVpos 59% PVneg 73%
23 Dis (VIR) DISCR
Alanine
300 U/l aminotransfer se PREV 16%
Fig. 5. Iramunoglobulin Μ is useless in the differentiation be-
tween extrahepatic and intrahepatic cholestasis. Disease
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PVneg 99% PVpos 76 %
Fig. 7. Double histogram of alanine aminotransferase values
in U/l »in patients with viral hepatitis ("diseased";
η = 23; top of graph) versus all other diagnostic groups
("reference"; η = 122; bottom of graph). At a eut-off
point of 300 U/l, this analyte possesses high diagnostic
power: sensitivity 96%, specificity 94%, PVpos 76%,
PVneg 99% (or 94% and 96%, respectively, at a "stand-
ard" disease prevalence of 50%).
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PVneg 100V. PVpos 22V. PVpos 30V. PVneg 100V.
Fig. 8. Lactate dehydrogenase has marginal usefulness for ex- Fig. 10. The ratio γ-glutamyltransferase/alanine aminotrans-
cluding viral hepatitis at values below 200 U/l (PVneg ferase has marginal usefulness for excluding viral hcp-
100%). atitis at values above 4. Note, that disease (viral hep-
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PVneg 92 V. PVpos 34V.
Fig. 9. Double histogram of erythrocyte sedimentation rate in
mm in the first hour in patients with acute intrahepatic
cholestasis ("diseased"; n = 23; top of graph) versus all
other diagnostic groups ("reference"; n = 121; bottom
of graph, one value missing in this group). At a cut-ofT
point above 30 mm, this analyte makes the diagnosis
of acute intrahepatic cholestasis very unlikely (PVneg
96%, albeit only 84% at a "standard" disease preva-
lence). Note that the "diseased" group is represented by
low values for this analyte.
Fig. 11. The ratio total bilirubin/y-glutamyltransferase has
marginal usefulness for excluding viral hepatitis al
values below 0.04 (PVneg. 92%).
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Fig. 13. Serum γ-globulin concentrations above 20 g/1 confirm
chronic parenchymal liver disease (PVpos 90%).
Fig. 15. Serum immunoglobulin A concentations above 9 g/1
confirm chronic parenchymal liver disease (PVpos
100%). The clinical usefulness is limited, considering
a sensitivity of 20%.
Discussion
The rate of morphological diagnostic proof obtained
in this study (72%) corresponds to other clinical in-
vestigations of cholestatic patients (e.g. 71% in the
study of Malchow-Moller (4)). It has to be kept in
mind that the patients described here were selected
for cholestasis, as indicated by elevated serum levels
of alkaline phosphatase and/or γ-glutarnyltransferase
and/or bilirubin. Therefore, data for tiie diagnostic
groups with viral hepatitis (VIR) and with chronic
parenchymal liver disease (CHR) will primarily apply
to«, those disease subgroups with more obvious cho-
lestatic features. With regard to.ithe evaluation of
diagnostic tests in cholestasis, this fact may place an
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even higher demand on their discriminatory power,
thus adding to rather than subtracting from the va-
lidity of the results reported here.
In addition to the well defined reference groups listed
in table 3, a number of other less prevalent disease
states possibly associated with cholestasis and not
included in this study have to be considered. However,
many of these less frequent diagnoses, like liver me-
tastases or ischaemic liver failure due to cardiac in-
sufficiency, are either readily diagnosed by ultrasono-
graphy or are readily suggested by the clinical setting
in which they occur. Thus they rarely cause much
diagnostic uncertainty. Nevertheless, the specificity
given in tables 4 to 6 is the specificity against the
background of those well defined, homogeneous dis-
eases making up the respective reference groups of
this study; the various further less prevalent diseases,
which may also present with cholestatic features, have
not been taken into consideration.
Extrahepatic versus in t rahepa t ic cholestasis
The graphical analyses presented here clearly confirm
that laboratory analytes like alkaline phosphatase, γ-
glutamyltransferase, leucine aminopeptidase and IgM
are of little help in the basic differentiation between
extrahepatic cholestasis and bile secretory failure due
to parenchymal liver disease (1, 5), when maximum
efficiency is selected as discriminator for a 2 χ 2 table
analysis.
This lack of useful discriminatory power also applies
to the ratio direct bilirubin/total bilirubin, as deter-
mined by the conventional diazo method (6). High
performance liquid chromatography (HPLC) after al-
kaline methanolysis has recently been introduced as
a specific method for estimating conjugated bilirubin
(7). Demonstration of esterified bilirubins in plasma
by this reaction appears to evolve as the single most
sensitive marker of hepatobiliary disease and may
serve to exclude Gilbert's syndrome by the detection
of appreciable amounts of such esters (7), but it like-
wise does not discriminate between extrahepatic or
intrahepatic variants of cholestatic disease. This dif-
ferentiation clearly is a domain of the imaging tech-
niques, especially ultrasonography.
The graphical display did reveal the clinical usefulness
of alkaline phosphatase (cut-off point 300 U/l; PVneg
92%, "standard" PVneg 89%; fig. 1), γ-glutamyl-
transferase (cut-off point 100 U/l; fig. 2) and direct
bilirubin/total bilirubin (cut-off point 0.4; fig. 4, tab.
4) for excluding extrahepatic obstruction in the ref-
erence groups. The double histograms thus show that
the clinically most meaningful discriminator position
docs not necessarily coincide with that giving the
highest Youden index, or maximum "efficiency". No
single cut-off point is appropriate for every diagnostic
demand. Discriminator positions rather have to be
tailored to satisfy specific needs, be it a search for
high positive or negative predictive values or maximal
efficiency. The optimal discriminator position for any
such diagnostic purpose can be easily gleaned from
the double histogram display of the computer graphs.
Such plots thus help to utilize the diagnostic potential
of the diagnostic variables to a fuller extent.
Viral hepati t is versus other hepa tobi l ia ry dis-
eases
On the contrary, the serum aminotransferases aspar-
tate aminotransferase and alanine aminotransferase
(figs. 6 — 7) are excellent criteria for the diagnosis of
acute viral hepatitis even at their maximal efficiency
value. At a cut-off point of 200 U/l and 300 U/l,
respectively, they had Youden indices well above 80%,
with sensitivity and specificity rates of 90% or higher,
while negative predictive values of 98% and 99% or
91 % and 96% at standard prevalence rates, respec-
tively, reliably excluded this diagnosis for values below
these discriminators (tab. 5). Like previous investi-
gators (1), we did not observe aminotransferases
above 500 U/l in the reference groups, thereby raising
the PVpos and the specificity at this cut-off point to
100% (figs. 6 — 7). However, the inclusion of other
reference groups such as hepatic ischaemia (8) would
appreciably subtract from the specificity associated
with this choice of discriminator position.
In addition to the aminotransferases, lactate dehydro-
genase and erythrocyte sedimentation rate were of
relevance for excluding the diagnosis of acute viral
hepatitis at specific cut-off points (figs 8 — 9). This
role of lactate dehydrogenase and erythrocyte sedi-
mentation rate was previously not fully appreciated.
With erythrocyte sedimentation rate l h and eryth-
rocyte sedimentation rate 2 h, "diseased" patients
with viral hepatitis are characterized by low rather
than high values of these variables. Therefore, sensi-
tivity and PVneg increase with higher values and
specificity and PVpos decrease (fig. 9), which is a
reverse of the situation where "disease" is character-
ized by high values, e. g. of aspartate aminotransferase
or alanine aminotransferase (figs. 6 — 7).
Chronic parenchymal liver disease versus oth-
ers
Further analyses showed that high serum γ-globulin
levels were helpful for the identification of chronic
J. Clin. Chem. Clin. Biochem. / Vol. 26, 1988 / No. 8
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intrahepatic choiestasis (PVpos 90% at a discrimina-
tor position of 20 g/1, given a prevalence for CHR of
40%: fig. 13). IgG and IgA had little and cholines-
terase no value in this regard (tab. 6; figs 14—16).





















































































































The best known ratio is De Ritis* aspartate
transferase/alanine aminotransferase* which has been
found to be elevated in patients with alcoholic hepa-
titis and cirrhosis (> 2, I.e. (10, 11)), postnecrotic
cirrhosis (1.74), chronic hepatitis, (1.3), but not ob-
structive jaundice (0.81) and viral hepatitis (0.74, I.e.
(10)). It has also been successfully used to differentiate
intrahepatic choiestasis from extrahep tic obstruction
in chronic alcoholic pancreatitis (12). This ratio like-
wise proved useful in the present study for the iden-
tification of chronic intrahepatic choiestasis. The cut-
off point giving the highest efficiency was 1.0. How-
ever, neither predictive value reached the 90% limit
at this level, making a cut-off point of 1.5 more
meaningful for individual diagnostic decisions (tab.
6; fig. 12). The γ-glutamyltransferase/alkaline phos-
phatase ratio (11) was useless in this regard (tab. 6).
PVpos 7A°/o PVneg72°/0
Fig. 16. Lack of usefulness of cholinesterase for the differen-
tiation of chronic parenchymal liver disease versus
other disease categories.
Further analytes and ratios
We also investigated several other diagnostic ratios in
addition to direct bilirubin/total bilirubin (fig. 4). The
ratio γ-glutamyltransferase/alanine aminotransferase
as described by Schmidt & Schmidt (1) was a useful
diagnostic parameter for acute viral hepatitis with a
Youden index of 57% and a PVneg of 100% at a cut-
off point of 4 (tab. 5; fig. 10). As with erythrocyte
sedimentation rate, "disease" is characterized by low
values of this index. The ratio total bilirubin/y-glu-
tamyltransferase as defined by Poynard et al. (9) is a
prognostic indicant in cirrhotic patients, high values
being associated with reduced survival. As indicated
in table 5, this ratio may also be used to make a
diagnosis of acute viral hepatitis unlikely (PVneg 92%
at a cut-off point of 0.04: fig. 11). However, the
apparent usefulness of this ratio probably depends to
some extent on a selection of patients with more
obvious cholestatic features in this series.
Conclusions
Computer-assisted graphical analyses shed some ad-
ditional light on the discriminatory power of conven-
tional laboratory analytes for the differentiation be-
tween extrahep tic choiestasis and choiestasis due to
acute or chronic parenchymal liver disease. Our ob-
servations confirm that aminotransferase levels are
excellent criteria for the diagnosis of acute viral hep-
atitis; to a lesser extent, this is also true for serum γ:
globulin concentrations and the De Ritis quotient with
regard to intrahepatic choiestasis due to chronic par-
enchymal liver disease. The analyses also point to the
additional, less appreciated value of lactate dehydro-
gen se, erythrocyte sedimentation fate and especially
of the ratio γ-glutamyltransferase/alanine amino-
transferase for the probabilistic exclusion of acute
viral hepatitis.
These graphical analyses by no means abolish uncer-
tainties in individual diagnostic decisions. They rather
allow a precise estimate of positive or negative like-
lihoods in these cases and thus help to clearly define
the magnitude of that uncertainty. Above all, they
readily and comprehensively display the entire distri-
bution of laboratory data in "disease" and reference
states and thus enable a more flexible usage and a
Puller exploitation of their true diagnostic potential.
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